共 13 条
[1]
G ene therapy trial for Parkinson s disease begins. O ransky I. The Lancet . 2003
[2]
Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Guo S,Bezard E,Zhao B. Free Radical Biology and Medicine . 2005
[3]
Melatonin and Parkinson’s disease. Mayo JC,Sainz RM,Tan DX,et al. Endocrine . 2005
[4]
Role of nitric oxide in Parkinson‘s disease. Zhang L,Dawson VL,Dawson TM. Pharmacology and Therapeutics . 2006
[5]
Rasagiline as an adjunct to levodopa in patients with Parkinson’s disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Rascol O,Brooks DJ,Melamed E,et al. The Lancet . 2005
[6]
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Youdim M B,Fridkin M,Zheng H,et al. Mechanisms of Ageing and Development . 2005
[7]
Smoking,nicotine and Parkinson s disease. Quik M. Trends in Neurosciences . 2004
[8]
Smoking, nicotine and Parkinson’s disease[J] . Maryka Quik.  Trends in Neurosciences . 2004 (9)
[10]
Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS–NO pathway[J] . Shuhong Guo,Erwan Bezard,Baolu Zhao.  Free Radical Biology and Medicine . 2005 (5)